This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sastre-Garriga, J. Articles by Montalban, X. Search for Related Content PubMed PubMed Citation Articles by Sastre-Garriga, J. Articles by Montalban, X. Social Bookmarking                   What's this?

Unconventional therapy in multiple sclerosis

Unitat de Neuroimmunologia Clínica, Hospital Universitari Vall d'Hebron, Barcelona, Spain, jsastre{at}hg.vhebron.es

Elvira Munteis

Hospital del Mar, Barcelona, Spain

Jordi Río

Unitat de Neuroimmunologia Clínica, Hospital Universitari Vall d'Hebron, Barcelona, Spain

Imma Pericot

Unitat de Neuroimmunologia Clínica, Hospital Universitari Vall d'Hebron, Barcelona, Spain

Mar Tintoré

Unitat de Neuroimmunologia Clínica, Hospital Universitari Vall d'Hebron, Barcelona, Spain

Xavier Montalban

Unitat de Neuroimmunologia Clínica, Hospital Universitari Vall d'Hebron, Barcelona, Spain

Background: The use of unconventional therapies is growing in western countries. Few studies on their frequency and rationale among multiple sclerosis (MS) patients have been carried out in Europe. Objective: To assess the frequency of use of unconventional therapies among MS patients and to explore associated clinical variables. Methods: Structured questionnaires were given to 380 consecutive patients seen at two hospital-based MS clinics in Barcelona. C linical and demographical data were recorded at the same time. The questionnaire inquired about demographical features, educatio n, income, use of unconventional therapies for MS and satisfaction with conventional medicine both in general and specifically in MS. Results: The response rate was 50.78%. Forty-one per cent of patients admitted using unconventional therapies during the previous year. Low levels of satisfaction with conventional medicine in general and for MS, and higher Expanded Disability Status Scale (EDSS) scores (EDSS mean: 4.43 in users versus 3.48 in nonusers) were significantly associated with use of unconventional therapies. Conclusion: Use of unconventional therapies is not rare among MS patients, and it is associated with high disability levels and dissatisfaction with conventional medicine.

Key Words: multiple sclerosis • alternative therapies • predictors of use • MS outpatient care • acupuncture • homeopathy

Multiple Sclerosis, Vol. 9, No. 3, 320-322 (2003)
DOI: 10.1191/1352458503ms913sr


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S Schwarz, C Knorr, H Geiger, and P Flachenecker Complementary and alternative medicine for multiple sclerosis Multiple Sclerosis, September 1, 2008; 14(8): 1113 - 1119. [Abstract] [PDF]

				K. Cetin, K.L. Johnson, D.M. Ehde, C.M. Kuehn, D. Amtmann, and G.H. Kraft Antidepressant use in multiple sclerosis: epidemiologic study of a large community sample Multiple Sclerosis, September 1, 2007; 13(8): 1046 - 1053. [Abstract] [PDF]